文献速递心律失常

不确定潜能克隆性造血预测新发心律失常

Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
PubMed 文献 · Eur Heart J · 2024-01-01

在UK Biobank无心律失常人群中,不确定潜能克隆性造血(CHIP)与室上性心律失常、缓慢性心律失常和室性心律失常新发风险独立相关,且独立于冠心病和心力衰竭;大CHIP还与心肌间质纤维化相关。

要点

  • CHIP携带者新发室上性、缓慢性和室性心律失常风险均升高,且独立于冠心病和心力衰竭。
  • 大CHIP(VAF≥10%)与心室心律失常关联更强,尤其在心脏骤停风险上关联最强。
  • 大CHIP与心脏磁共振T1测定的心肌间质纤维化处于最高五分位几率升高相关。

核心结论

  • CHIP可能代表新发心律失常的新型危险因素,提示其作为心律失常预防和治疗调控靶点的潜力。

研究设计与样本

  • 基于UK Biobank无现患心律失常参与者的前瞻性队列研究,共纳入410 702人。
  • CHIP定义为变异等位基因分数(VAF)≥2%,大CHIP定义为VAF≥10%。
  • 采用多变量校正Cox回归评估CHIP与新发心律失常的关联。

主要发现

  • 任何CHIP(n=13 892,3.4%)与大CHIP(n=9191,2.2%)与室上性心律失常的多变量校正风险比分别为1.11(95%CI 1.04-1.18;P=.001)和1.13(95%CI 1.05-1.22;P=.001)。
  • 任何CHIP与大CHIP与缓慢性心律失常的风险比分别为1.09(95%CI 1.01-1.19;P=.031)和1.13(95%CI 1.03-1.25;P=.011)。
  • 任何CHIP与大CHIP与室性心律失常的风险比分别为1.16(95%CI 1.00-1.34;P=.049)和1.22(95%CI 1.03-1.45;P=.021)。
  • 关联独立于冠心病和心力衰竭,且在不同心律失常亚型间存在异质性,其中心脏骤停关联最强。
  • 大CHIP与心肌磁共振T1测定的心肌间质纤维化处于最高五分位的比值比为1.31(95%CI 1.07-1.59;P=.009)。

临床怎么用

  • 对CHIP携带者(尤其大CHIP)可考虑加强心律失常监测与风险评估,但需进一步研究验证。
  • CHIP相关风险独立于传统冠心病和心衰,提示心律失常风险评估可能需纳入CHIP状态。
  • 大CHIP与心肌纤维化相关,提示CHIP相关心律失常风险可能部分由纤维化介导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Clonal haematopoiesis of indeterminate potential (CHIP), the age-related expansion of blood cells with preleukemic mutations, is associated with atherosclerotic cardiovascular disease and heart failure. This study aimed to test the association of CHIP with new-onset arrhythmias. METHODS: UK Biobank participants without prevalent arrhythmias were included. Co-primary study outcomes were supraventricular arrhythmias, bradyarrhythmias, and ventricular arrhythmias. Secondary outcomes were cardiac arrest, atrial fibrillation, and any arrhythmia. Associations of any CHIP [variant allele fraction (VAF) ≥ 2%], large CHIP (VAF ≥10%), and gene-specific CHIP subtypes with incident arrhythmias were evaluated using multivariable-adjusted Cox regression. Associations of CHIP with myocardial interstitial fibrosis [T1 measured using cardiac magnetic resonance (CMR)] were also tested. RESULTS: This study included 410 702 participants [CHIP: n = 13 892 (3.4%); large CHIP: n = 9191 (2.2%)]. Any and large CHIP were associated with multi-variable-adjusted hazard ratios of 1.11 [95% confidence interval (CI) 1.04-1.18; P = .001] and 1.13 (95% CI 1.05-1.22; P = .001) for supraventricular arrhythmias, 1.09 (95% CI 1.01-1.19; P = .031) and 1.13 (95% CI 1.03-1.25; P = .011) for bradyarrhythmias, and 1.16 (95% CI, 1.00-1.34; P = .049) and 1.22 (95% CI 1.03-1.45; P = .021) for ventricular arrhythmias, respectively. Associations were independent of coronary artery disease and heart failure. Associations were also heterogeneous across arrhythmia subtypes and strongest for cardiac arrest. Gene-specific analyses revealed an increased risk of arrhythmias across driver genes other than DNMT3A. Large CHIP was associated with 1.31-fold odds (95% CI 1.07-1.59; P = .009) of being in the top quintile of myocardial fibrosis by CMR. CONCLUSIONS: CHIP may represent a novel risk factor for incident arrhythmias, indicating a potential target for modulation towards arrhythmia prevention and treatment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Schuermans A, Vlasschaert C, Nauffal V, et al. Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias. Eur Heart J. 2024. PMID: 37952204. doi:10.1093/eurheartj/ehad670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。